Latest EDGAR 4 filed on 2026-06-03, report date 2026-06-01: PYOTT DAVID E I / ALNYLAM PHARMACEUTICALS, INC. reports ownership changes; on 06/01/2026; in Common Stock; including 3,830 shares at 921 per share; 5,412 shares at 921 per share; 4,491 shares at 298.91 per share; 1,175 shares at 298.91 per share; 3,316 shares at 299.87 per share; 1,222 shares at 299.87 per share; 2,094 shares at 495 per share; 1,599 shares at 302.65 per share; 1. The transactions reported on this Form 4 were made pursuant to a Rule 10b5-1(c) trading plan adopted by the reporting person on November 12, 2025. The options exercised by the reporting person were due to expire on June 3, 2026. 2. The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $297.31 to $297.99. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. 3. The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $298.33 to $299.33. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. 4. The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $299.36 to $300.19. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. 5. The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $300.45 to $301.15. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. 6. The shares of ALNY common stock were purchased by the David E I Pyott Trust, of which the reporting person is trustee. 7.
Stock detail
Alnylam Pharmaceuticals, Inc. (ALNY) stock price, chart, and key data
View Alnylam Pharmaceuticals, Inc. stock price, chart movement, and headline metrics on Woodstock's stock detail page.
Stock detail
Alnylam Pharmaceuticals, Inc.
ALNY · XNAS
+$21.93 (+8.13%) past day
$291.68
Overnight $291.71 (+0.01%)
Key metrics
Earnings
Quarterly results and the next expected release
FY25 Q2
Q3
Q4
FY26 Q1
Q2
Q3
Day range
$263.86 - $275.48
52-week range
$262.21 - $495.55
Close price
$268.74
Market cap
$35.9B
P/E ratio
193.16
Beta
0.27
About the company
Alnylam Pharmaceuticals, Inc
Alnylam Pharmaceuticals, Inc. is an American biopharmaceutical company focused on the discovery, development and commercialization of RNA interference therapeutics for genetically defined diseases. The company was founded in 2002 and is headquartered in Cambridge, Massachusetts. In 2016, Forbes included the company on its "100 Most Innovative Growth Companies" list.
Ticker holders
Review politician disclosures and insider transactions in tabs.
Holder directory
Select a heading to reorder by name, activity date, buy/sell, or displayed value.
#1Dan Goldman
democrat · House · NY-10
- Buy$15,001 / $32,501 / $50,000
- Sell$15,001 / $32,501 / $50,000
#2Josh Gottheimer
democrat · House · NJ-5
- Sell$1,000 / $8,000 / $15,000
- Buy$1,000 / $8,000 / $15,000
- Buy$1,001 / $8,001 / $15,000
- Sell$1,000 / $8,000 / $15,000
- Sell$1,001 / $8,001 / $15,000
- Buy$1,000 / $8,000 / $15,000
#3Jefferson Shreve
republican · House · IN-6
- Sell$15,001 / $32,501 / $50,000
#4Ro Khanna
democrat · House · CA-17
- Sell$1,000 / $8,000 / $15,000
#5Donald J Trump
republican · Executive
Market action
A concise summary of the latest filing, transaction, or market-moving item.
24/5 Trading
Act on the stock when the timing works for you.
With Woodstock, you can move from chart review to order placement in one flow. Trade eligible US stocks 24/5, even outside regular market hours.
*24-hour trading is available except during system maintenance. Some stocks are not eligible for extended-hours trading.
Download the app